| Dr Jie Xu, MD | |
|
1098 W Baltimore Pike, Suite 3106 Riddle Health Center 3, Media, PA 19063-5139 | |
| (610) 891-6240 | |
| (610) 891-6244 |
| Full Name | Dr Jie Xu |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 1098 W Baltimore Pike, Media, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588895767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD446024 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paoli Hospital | Paoli, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Womens Health Group Llc | 2961316328 | 334 |
News Archive
A University of Toronto Scarborough (UTSC) researcher is examining how environmental triggers might alter gene function in people with Chronic Fatigue Syndrome. The research could lead to better insights into the disease and eventually to new treatments.
Auditor General Jack Wagner said today that he stood by the Department of the Auditor General's finding of double-digit error rates in Pennsylvania's Medicaid program, and cast doubt on a federal report that coincided with the commonwealth's claim that the program's error rate was only 4 percent.
Researchers from Cardiff University and Université Libre de Bruxelles have identified how the function of a key gene significantly impacts nerve stem cell growth, and how it can lead to abnormal brain development in unborn babies if the system goes awry.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer's disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital.
› Verified 9 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
A University of Toronto Scarborough (UTSC) researcher is examining how environmental triggers might alter gene function in people with Chronic Fatigue Syndrome. The research could lead to better insights into the disease and eventually to new treatments.
Auditor General Jack Wagner said today that he stood by the Department of the Auditor General's finding of double-digit error rates in Pennsylvania's Medicaid program, and cast doubt on a federal report that coincided with the commonwealth's claim that the program's error rate was only 4 percent.
Researchers from Cardiff University and Université Libre de Bruxelles have identified how the function of a key gene significantly impacts nerve stem cell growth, and how it can lead to abnormal brain development in unborn babies if the system goes awry.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer's disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital.
› Verified 9 days ago
| Entity Name | Regional Womens Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750880118 PECOS PAC ID: 2961316328 Enrollment ID: O20180611002120 |
News Archive
A University of Toronto Scarborough (UTSC) researcher is examining how environmental triggers might alter gene function in people with Chronic Fatigue Syndrome. The research could lead to better insights into the disease and eventually to new treatments.
Auditor General Jack Wagner said today that he stood by the Department of the Auditor General's finding of double-digit error rates in Pennsylvania's Medicaid program, and cast doubt on a federal report that coincided with the commonwealth's claim that the program's error rate was only 4 percent.
Researchers from Cardiff University and Université Libre de Bruxelles have identified how the function of a key gene significantly impacts nerve stem cell growth, and how it can lead to abnormal brain development in unborn babies if the system goes awry.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer's disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jie Xu, MD 1098 W Baltimore Pike, Suite 3106 Riddle Health Center 3, Media, PA 19063-5139 Ph: (610) 891-6240 | Dr Jie Xu, MD 1098 W Baltimore Pike, Suite 3106 Riddle Health Center 3, Media, PA 19063-5139 Ph: (610) 891-6240 |
News Archive
A University of Toronto Scarborough (UTSC) researcher is examining how environmental triggers might alter gene function in people with Chronic Fatigue Syndrome. The research could lead to better insights into the disease and eventually to new treatments.
Auditor General Jack Wagner said today that he stood by the Department of the Auditor General's finding of double-digit error rates in Pennsylvania's Medicaid program, and cast doubt on a federal report that coincided with the commonwealth's claim that the program's error rate was only 4 percent.
Researchers from Cardiff University and Université Libre de Bruxelles have identified how the function of a key gene significantly impacts nerve stem cell growth, and how it can lead to abnormal brain development in unborn babies if the system goes awry.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer's disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital.
› Verified 9 days ago
Sean Mcconnell, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1088 W Baltimore Pike, Hcc Ii, Suite 2303, Media, PA 19063 Phone: 610-627-4400 Fax: 610-627-4408 | |
Dr. Mitchell B Berger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1098 W Baltimore Pike Ste 3404, Media, PA 19063 Phone: 610-627-4170 Fax: 610-627-4224 | |
Rosalia Hyatt, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1098 W Baltimore Pike, Suite 3106 Riddle Hlth Ctr 3, Media, PA 19063 Phone: 610-891-6240 Fax: 610-891-6244 | |
Christopher J Lobo, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1098 W Baltimore Pike, Suite 3106 Riddle Hlth Ctr 3, Media, PA 19063 Phone: 610-891-6240 Fax: 610-891-6244 | |
Lane K. Shima, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1098 W Baltimore Pike, Suite 3109, Media, PA 19063 Phone: 484-443-2880 Fax: 484-443-2885 | |
Hilary C Hinton, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1098 W Baltimore Pike Ste 3109, Media, PA 19063 Phone: 484-443-2880 Fax: 484-443-2885 | |
Dr. Frank J. White, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1088 W. Baltimore Pk, Hcc Ii, Suite 2303, Media, PA 19063 Phone: 610-627-4400 Fax: 888-209-3560 |